30 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
20
Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones.

Universidade Federal De Minas Gerais
7
Design, synthesis and biological evaluation of novel nitroaromatic compounds as potent glutathione reductase inhibitors.

Batman University
12
In vitro inhibition of human erythrocyte glutathione reductase by some new organic nitrates.

Ataturk University
13
High-throughput screening affords novel and selective trypanothione reductase inhibitors with anti-trypanosomal activity.

Harvard Medical School
6
Inhibitors of Trypanosoma cruzi trypanothione reductase revealed by virtual screening and parallel synthesis.

Universit£T Heidelberg
20
Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.

University of Manchester
20
Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.

TBA
9
Optimising inhibitors of trypanothione reductase using solid-phase chemistry.

University of Southamton
78
Dihydroquinazolines as a novel class of Trypanosoma brucei trypanothione reductase inhibitors: discovery, synthesis, and characterization of their binding mode by protein crystallography.

University of Dundee
3
Compounds structurally related to ellagic acid show improved antiplasmodial activity.

Justus-Liebig-University
32
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis.

National Human Genome Research Institute
1
Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum.

Biochemie-Zentrum Der Universit£T Heidelberg
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.

University of Cambridge
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.

Johann Wolfgang Goethe University
1
Pleiotropic effects of a mitochondrion-targeted glutathione reductase inhibitor on restraining tumor cells.

The Affiliated Hospital of Qingdao University
38
Polyamine-based analogs and conjugates as antikinetoplastid agents.

Univ Paris Sud
3
Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening.

Institute of Medical Research
14
Novel alkylpolyaminoguanidines and alkylpolyaminobiguanides with potent antitrypanosomal activity.

Wayne State University
1
Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.

Biochemie-Zentrum Der UniversitäT Heidelberg
2
Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors.

Umr 8525 Cnrs-Université
5
5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials.

Université
4
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.

Umr 8525 Cnrs-Université
8
Antiprotozoal and cytotoxicity evaluation of sulfonamide and urea analogues of quinacrine.

University of Cape Town
21
Inhibition of human glutathione reductase by 10-arylisoalloxazines: crystalline, kinetic, and electrochemical studies.

Institut FüR Biochemie Ii Der UniversitäT
302
Substituted 6-azabenzimidazole compounds

Gilead Sciences
42
Inhibitors of dihydroceramide desaturase for treating disease

Centaurus Therapeutics
44
Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer

Nodus Oncology
150
Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof

Wigen Biomedicine Technology (Shanghai)
40
Dihydrofolate reductase inhibitors

Trius Therapeutics
422
Aminopyrazoloquinazolines

Boehringer Ingelheim International